You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • TP023/#61  An prospective, single-arm, phase II study of alternating regimens of fluzoparib and oral etoposide maintenance therapy, in newly diagnosed advanced ovarian cancer: fare trial

Citation Tools

Article menu

Download PDFPDF

ePoster Viewing: Trials-in-Progress
AS11. Ovarian cancer
TP023/#61  An prospective, single-arm, phase II study of alternating regimens of fluzoparib and oral etoposide maintenance therapy, in newly diagnosed advanced ovarian cancer: fare trial
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Wang Y, Tong R, Li X, et al
TP023/#61  An prospective, single-arm, phase II study of alternating regimens of fluzoparib and oral etoposide maintenance therapy, in newly diagnosed advanced ovarian cancer: fare trial
International Journal of Gynecologic Cancer 2023;33:A256.